Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new factor X defect (factor X Padua 3): a compound heterozygous between true deficiency (Gly(380)-->Arg) and an abnormality (Ser(334)-->Pro).

Thrombosis research - 15 Nov 2001

Vianello F, Lombardi A M, Boldrin C, Luni S, Girolami A

Abstract excerpt

We report a novel mutation in Factor X (FX) gene which results in a phenotype without any bleeding tendency. The proband has been found to be a compound heterozygote between a novel FX true deficiency (Gly(380)-->Arg) and a previously reported dysfunctional mutation Ser(334)-->Pro (FX Marsiglia). Prothrombin time (PT) and partial thromboplastin time (PTT) were moderately prolonged and were fully corrected by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Factor X

Share to Family Health

Share to Heterozygote

Share to Mutation, Missense

Share to Partial Thromboplastin Time

Source

Identifiers

PMID: 11728527
DOI: 10.1016/s0049-3848(01)00371-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new factor X defect (factor X Padua 3): a compound heterozygous between true deficiency (Gly(380)-->Arg) and an abnormality (Ser(334)-->Pro).PMID 11728527Read ↗

A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain.Semantic proximity Read ↗

[Inherited coagulation factor X deficiency caused by two novel mutations in factor X gene].Semantic proximity Read ↗

Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical Hemorrhage.Semantic proximity Read ↗

Gene variants in four pedigrees with hereditary coagulation factor XI deficiency and one novel mutation identification.Semantic proximity Read ↗

Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency.Semantic proximity Read ↗

A dysfunctional factor X (factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (delC556) and missense mutation (Lys(408)-->Asn) in the factor X gene. A study of an Italian family.Semantic proximity Read ↗

Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain.Semantic proximity Read ↗

Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site.Semantic proximity Read ↗

A family with factor X deficiency from Argentina: a compound heterozygosis because of the combination of a new mutation (Gln138Arg) with an already known one (Glu350Lys).Semantic proximity Read ↗

[Genotypic and phenotypic analysis of a case with inherited coagulation factor X deficiency].Semantic proximity Read ↗

Two novel factor X gene mutations in a Chinese family with factor X deficiency.Semantic proximity Read ↗

Factor X Stockton: a mild bleeding diathesis associated with an active site mutation in factor X.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.